Centessa Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Centessa Pharmaceuticals generated cash of -$160,342,000, which is more than the previous year. Cash used in financing activities reached the amount of $21,117,000 last year. Net change in cash is therefore -$265,614,000.
Cash Flow
| 2019 | -5.82M | 0 | 9.00M |
|---|---|---|---|
| 2020 | -10.63M | 0 | 1.36M |
| 2021 | -136.14M | 63.24M | 660.06M |
| 2022 | -200.54M | -931K | 457K |
| 2023 | -160.34M | -127.00M | 21.11M |
CNTA Cash Flow Statement (2019 β 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 393.64M | 595.08M | 5.00M | 16.57M | 12.87M |
Operating activities | |||||
Net income | -151.08M | -216.20M | -381.85M | -10.66M | -5.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 810K | 131K | 33.99K | 0 | 6K |
Stock-based compensation expense | 29.39M | 24.96M | 14.85M | 336K | 236K |
| Deferred income tax benefit | 29.39M | 24.96M | 14.85M | 336K | 236K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | -11.70M | -6.72M | 0 | 0 |
Inventories | 0 | 11.70M | -4.15M | 0 | 0 |
Accounts payable | -2.73M | 6.35M | 4.15M | -49K | 855K |
Cash generated by operating activities | -160.34M | -200.54M | -136.14M | -10.63M | -5.82M |
Investing activities | |||||
Purchases Of Investments | -126.83M | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -169K | -1.13M | -185.97K | 0 | 0 |
Acquisitions Net | 0 | 0 | 63.43M | 0 | 0 |
Cash generated by investing activities | -127.00M | -931K | 63.24M | 0 | 0 |
Financing activities | |||||
Common Stock Issued | 20.80M | 717.55K | 586.44M | 10.07K | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -11.99K | 0 | 0 |
Repayments of term debt | 0 | 0 | -73.63M | -5.03M | 3.83M |
Cash used in financing activities | 21.11M | 457K | 660.06M | 1.36M | 9.00M |
Net Change In Cash | -265.61M | -201.43M | 590.07M | -9.34M | 3.7M |
Cash at end of period | 128.03M | 393.64M | 595.08M | 7.22M | 16.57M |
| Data source | Data source | Data source |